Article
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2015
Gustafson Michael P, Lin Yi, Bleeker Jonathan S, Warad Deepti, Tollefson Matthew K, Crispen Paul L, Bulur Peggy A, Harrington Susan M, Laborde Rebecca R, Gastineau Dennis A, Leibovich Bradley C, Cheville John C, Kwon Eugene D, Dietz Allan B
Abstract excerpt
PURPOSE: Immunotherapeutic strategies to treat patients with renal cell carcinoma (RCC) offer new opportunities for disease management. Further improvements to immunotherapy will require additional understanding of the host response to RCC development. EXPERIMENTAL DESIGN: Using a novel approach to understanding the immune status of cancer patients, we previously showed that patients with a certain immune profile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
